Deborah Persaud

Quick Facts

Full Name	Deborah Persaud
Occupation	Scientist
Date Of Birth	Aug 23, 1960(1960-08-23)
Age	64
Birthplace	Guyana
Horoscope	Capricorn

Deborah Persaud Biography

Deborah Persaud is one of the most popular and richest Scientist who was born on August 23, 1960 in Guyana, ****. Persaud was born on 23 August 1960 in Guyana, South America. At age 16 she moved to Brooklyn. Persaud attended the New York University School of Medicine after receiving her undergraduate degree from York College CUNY. She also earned a master’s degree at the New York University School of Medicine. She started Residency at the Babies Hospital of New York and finished her Chief Residency at the same hospital. Persaud later was a fellow at the New York University School of Medicine. She began her academic career as an Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine from 1997 to

2004. In 2005, Persaud became an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine.

In 2013 Persaud worked as part of a team who showed that a baby had been cured of HIV by giving it anti-HIV drugs; she won the Elizabeth Glaser Scientist Award and was featured in Time magazine’s Top 100 most influential people in 2013 for her research and clinical works in pediatric HIV and AIDS. She was also included in Nature’s 10 for 2013, by the journal Nature. In 2014 Persaud’s work contributed to a second baby being cured of HIV.

Deborah Persaud Net Worth

Deborah Persaud is one of the richest Scientist from . According to our analysis, Wikipedia, Forbes & Business Insider, Deborah Persaud 's net worth $5 Million. (Last Update: December 11, 2023)

Deborah Persaud (born 23 August 1960) is an South America-born American virologist who primarily works on HIV/AIDS at Johns Hopkins Children’s Center.

The main topic of Persaud’s research is AIDS and HIV of children. However, her research started from research about HIV in adults. In 2003, she stated about the Human Immunodeficiency Virus (HIV)- type1 included in the subtypes of HIV. For the HIV patient, the HAART(Highly active antiretroviral therapy) is used as treatment. The HAART regimen includes some drugs containing Nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitor (PI), and non- nucleoside reverse transcriptase inhibitors (NNRTI). The HAART has important function to suppress the levels of HIV-1 to below quantification. HIV-1 persists in cellular reservoirs of CD4+ continually with low-level viremia in adults, and this is very sensitive. Persaud and her research team found that viremia persists in children with plasma virus remaining at a level under the limit of detection of clinical assays. When children with HIV-1 receive HAART treatment, the viremia that is difficult to observe is continued virus production without resistance in the protease gene. Persaud’s research team tried to find a novel culture assay that can stimulate the virus production during their latent, integrated HIV-1 in resting CD4+ T cells with the antiretroviral drugs. These drugs interfere with the replication of unintegrated virus. They also demonstrated the facts that HIV-1 polymerase sequences from the resting CD4+ T cells of the patients. By following this research, her research topic has been about antiretroviral therapy. In 2009, her research team focused on the ongoing human immunodeficiency virus type 1 (HIV-1). From this research, it was figured out ongoing virus replication contributes to low-level viremia in patients on HAART, and this ongoing replication is subject to CD8+ T-cell selective pressure. After that, she suggested the induction therapy by using protease-inhibitors has influenced the effect of NNRTI (non-Nucleoside reverse transcriptase inhibitors) resistance on virologic response to nevirapine-based HAART in children patients of HIV. For a long time, her research topic has been focusing on the therapy of HIV-1 especially with the child patients. In order to develop the therapy, she has been explained about the mechanism using the NNRTI of HAART.

Height, Weight & Body Measurements

Deborah Persaud height Not available right now. Deborah weight Not Known & body measurements will update soon.

Who is Deborah Persaud Dating?

According to our records, Deborah Persaud is possibily single & has not been previously engaged. As of December 1, 2023, Deborah Persaud’s is not dating anyone.

Relationships Record : We have no records of past relationships for Deborah Persaud. You may help us to build the dating records for Deborah Persaud!

Facts & Trivia

Deborah Ranked on the list of most popular Scientist. Also ranked in the elit list of famous people born in. Deborah Persaud celebrates birthday on August 23 of every year.

Top Facts about Deborah Persaud

1. Deborah Persaud is a South America-born American virologist.
2. She played a key role in the first documented case of HIV cure in an infant.
3. Persaud received her medical degree from the University of Puerto Rico.
4. She completed her residency and fellowship at Johns Hopkins Hospital.
5. Persaud has published numerous articles on pediatric HIV treatment and cure research.
6. She is currently a professor of pediatrics at John Hopkins School of Medicine.
7. In 2013, she was named one of Time Magazine’s 100 most influential people.
8. Persaud continues to conduct research on HIV cure strategies for children and adults.
9. Her work has led to advancements in understanding how HIV persists in the body.
10. Persaud’s contributions have helped pave the way towards finding a cure for HIV/AIDS.